Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-21-000474
Accepted
2021-02-08 00:15:26
Documents
1
Effectiveness Date
2021-02-05
Registration Form
S-1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 595
  Complete submission text file 9999999995-21-000474.txt   1746
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-252482 | Film No.: 21598373
SIC: 2836 Biological Products, (No Diagnostic Substances)